MYLAN 2036 MYLAN 2036 (Topiramate (Sprinkle) 25 mg)
Pill with imprint MYLAN 2036 MYLAN 2036 is Pink, Capsule-shape and has been identified as Topiramate (Sprinkle) 25 mg. It is supplied by Mylan Pharmaceuticals Inc.
Topiramate is used in the treatment of lennox-gastaut syndrome; epilepsy; seizure prevention; migraine prevention; seizures and belongs to the drug class carbonic anhydrase inhibitor anticonvulsants. There is positive evidence of human fetal risk during pregnancy. Topiramate 25 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for MYLAN 2036 MYLAN 2036
Topiramate (Sprinkle)
- Imprint
- MYLAN 2036 MYLAN 2036
- Strength
- 25 mg
- Color
- Pink
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- Carbonic anhydrase inhibitor anticonvulsants
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Mylan Pharmaceuticals Inc.
- National Drug Code (NDC)
- 00378-2036 (Discontinued)
More about topiramate
- Side effects
- Drug interactions
- Dosage information
- During pregnancy or Breastfeeding
- Reviews (1,228)
- Patient tips
- Drug images
- Compare alternatives
- Pricing & coupons
- En español
- Drug class: carbonic anhydrase inhibitor anticonvulsants
Patient resources
- Drug Information
- Topiramate (Advanced Reading)
- Topiramate Extended-Release Capsules
- Topiramate Extended-Release Sprinkle Capsules
- Topiramate Tablets
- Topiramate Sprinkle Capsules
- Other brands
- Topamax, Trokendi XR, Topamax Sprinkle, Qudexy XR, ... +2 more
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.